Literature DB >> 26350304

Multidimensional anatomy of 'modern type depression' in Japan: A proposal for a different diagnostic approach to depression beyond the DSM-5.

Takahiro A Kato1,2, Ryota Hashimoto3,4, Kohei Hayakawa1, Hiroaki Kubo1, Motoki Watabe5, Alan R Teo6,7, Shigenobu Kanba1.   

Abstract

Japan's prototype of depression was traditionally a melancholic depression based on the premorbid personality known as shūchaku-kishitsu proposed by Mitsuzo Shimoda in the 1930s. However, since around 2000, a novel form of depression has emerged among Japanese youth. Called 'modern type depression (MTD)' by the mass media, the term has quickly gained popularity among the general public, though it has not been regarded as an official medical term. Likewise, lack of consensus guidelines for its diagnosis and treatment, and a dearth of scientific literature on MTD has led to confusion when dealing with it in clinical practice in Japan. In this review article, we summarize and discuss the present situation and issues regarding MTD by focusing on historical, diagnostic, psychosocial, and cultural perspectives. We also draw on international perspectives that begin to suggest that MTD is a phenomenon that may exist not only in Japan but also in many other countries with different sociocultural and historical backgrounds. It is therefore of interest to establish whether MTD is a culture-specific phenomenon in Japan or a syndrome that can be classified using international diagnostic criteria as contained in the ICD or the DSM. We propose a novel diagnostic approach for depression that addresses MTD in order to combat the current confusion about depression under the present diagnostic systems.
© 2015 The Authors. Psychiatry and Clinical Neurosciences © 2015 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  DSM-5; atypical depression; depression; dysthymia; major depressive disorder; shūchaku-kishitsu

Mesh:

Year:  2015        PMID: 26350304      PMCID: PMC5560068          DOI: 10.1111/pcn.12360

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  50 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

Review 2.  The what, how, why, and where of self-construal.

Authors:  Susan E Cross; Erin E Hardin; Berna Gercek-Swing
Journal:  Pers Soc Psychol Rev       Date:  2010-08-17

3.  [Clinical classification of depression].

Authors:  Y Kasahara; B Kimura
Journal:  Seishin Shinkeigaku Zasshi       Date:  1975-10-25

4.  Hysteroid dysphoria.

Authors:  D F Klein; M R Liebowitz
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

5.  Comparative epidemiology of suicide in South Korea and Japan: effects of age, gender and suicide methods.

Authors:  Seong Yi Kim; Myoung-Hee Kim; Ichiro Kawachi; Youngtae Cho
Journal:  Crisis       Date:  2011

Review 6.  Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?

Authors:  T A Kato; A Monji; Y Mizoguchi; S Hashioka; H Horikawa; Y Seki; M Kasai; H Utsumi; S Kanba
Journal:  Mini Rev Med Chem       Date:  2011-06       Impact factor: 3.862

7.  Culture, cultural factors and psychiatric diagnosis: review and projections.

Authors:  Renato D Alarcón
Journal:  World Psychiatry       Date:  2009-10       Impact factor: 49.548

8.  Self responses along cingulate cortex reveal quantitative neural phenotype for high-functioning autism.

Authors:  Pearl H Chiu; M Amin Kayali; Kenneth T Kishida; Damon Tomlin; Laura G Klinger; Mark R Klinger; P Read Montague
Journal:  Neuron       Date:  2008-02-07       Impact factor: 17.173

9.  Minocycline modulates human social decision-making: possible impact of microglia on personality-oriented social behaviors.

Authors:  Takahiro A Kato; Motoki Watabe; Sho Tsuboi; Katsuhiko Ishikawa; Kazuhide Hashiya; Akira Monji; Hideo Utsumi; Shigenobu Kanba
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

10.  Impaired social decision making in patients with major depressive disorder.

Authors:  Hui-Jun Zhang; Delin Sun; Tatia M C Lee
Journal:  Brain Behav       Date:  2012-07       Impact factor: 2.708

View more
  15 in total

1.  Hikikomori: experience in Japan and international relevance.

Authors:  Takahiro A Kato; Shigenobu Kanba; Alan R Teo
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

2.  Preliminary study of the social withdrawal (hikikomori) spectrum in French adolescents: focusing on the differences in pathology and related factors compared with Japanese adolescents.

Authors:  Yukiko Hamasaki; Nancy Pionnié-Dax; Géraldine Dorard; Nicolas Tajan; Takatoshi Hikida
Journal:  BMC Psychiatry       Date:  2022-07-16       Impact factor: 4.144

3.  Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis.

Authors:  Daiki Setoyama; Takahiro A Kato; Ryota Hashimoto; Hiroshi Kunugi; Kotaro Hattori; Kohei Hayakawa; Mina Sato-Kasai; Norihiro Shimokawa; Sachie Kaneko; Sumiko Yoshida; Yu-Ichi Goto; Yuka Yasuda; Hidenaga Yamamori; Masahiro Ohgidani; Noriaki Sagata; Daisuke Miura; Dongchon Kang; Shigenobu Kanba
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

4.  Use of Interpersonal Counseling for Modern Type Depression.

Authors:  Hisae Ono; Ami Yamamoto; Reiko Taketani; Emi Tsujimoto
Journal:  Case Rep Psychiatry       Date:  2017-10-25

5.  Blood biomarkers of Hikikomori, a severe social withdrawal syndrome.

Authors:  Kohei Hayakawa; Takahiro A Kato; Motoki Watabe; Alan R Teo; Hideki Horikawa; Nobuki Kuwano; Norihiro Shimokawa; Mina Sato-Kasai; Hiroaki Kubo; Masahiro Ohgidani; Noriaki Sagata; Hiroyuki Toda; Masaru Tateno; Naotaka Shinfuku; Junji Kishimoto; Shigenobu Kanba
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

6.  Development of MHFA-based 2-h educational program for early intervention in depression among office workers: A single-arm pilot trial.

Authors:  Hiroaki Kubo; Hiromi Urata; Ryoko Katsuki; Miyako Hirashima; Shion Ueno; Yuriko Suzuki; Daisuke Fujisawa; Naoki Hashimoto; Keiji Kobara; Tetsuji Cho; Toshiko Mitsui; Shigenobu Kanba; Kotaro Otsuka; Takahiro A Kato
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

7.  Hikikomori Phenomenon in East Asia: Regional Perspectives, Challenges, and Opportunities for Social Health Agencies.

Authors:  John Chee Meng Wong; Michelle Jing Si Wan; Leoniek Kroneman; Takahiro A Kato; T Wing Lo; Paul Wai-Ching Wong; Gloria Hongyee Chan
Journal:  Front Psychiatry       Date:  2019-07-23       Impact factor: 4.157

8.  Development of 5-day hikikomori intervention program for family members: A single-arm pilot trial.

Authors:  Hiroaki Kubo; Hiromi Urata; Motohiro Sakai; Shunsuke Nonaka; Kazuhiko Saito; Masaru Tateno; Keiji Kobara; Naoki Hashimoto; Daisuke Fujisawa; Yuriko Suzuki; Kotaro Otsuka; Hiroho Kamimae; Yuya Muto; Takashi Usami; Yoko Honda; Junji Kishimoto; Toshihide Kuroki; Shigenobu Kanba; Takahiro A Kato
Journal:  Heliyon       Date:  2020-01-09

9.  Network analysis of the depressive symptom profiles in Asian patients with depressive disorders: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD).

Authors:  Seon-Cheol Park; Eun Young Jang; Yu-Tao Xiang; Shigenobu Kanba; Takahiro A Kato; Mian-Yoon Chong; Shih-Ku Lin; Shu-Yu Yang; Ajit Avasthi; Sandeep Grover; Roy A Kallivayalil; Pichet Udomratn; Kok Yoon Chee; Andi J Tanra; Chay-Hoon Tan; Kang Sim; Norman Sartorius; Yong Chon Park; Naotaka Shinfuku
Journal:  Psychiatry Clin Neurosci       Date:  2020-03-05       Impact factor: 5.188

10.  Family Features of Social Withdrawal Syndrome (Hikikomori).

Authors:  Ángeles Malagón-Amor; Luis Miguel Martín-López; David Córcoles; Anna González; Magda Bellsolà; Alan R Teo; Antoni Bulbena; Víctor Pérez; Daniel Bergé
Journal:  Front Psychiatry       Date:  2020-03-02       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.